Document is current
Any future updates will be listed below
-
Authors
Alsanie, Ibrahim
Shephard, Adam
Azarmehr, Neda
Vargas, Pablo
Pring, Miranda
Rajpoot, Nasir M. https://orcid.org/0000-0001-6760-1271
Khurram, Syed Ali https://orcid.org/0000-0002-0378-9380
-
Funding
Funding for this research was provided by:
Adenoid Cystic Carcinoma Research Foundation
LifeArc
PhD studentship- King Saud University, Saudi Arabia
- License Information
-
More Information
Article History
Received: 4 August 2023
Accepted: 5 August 2025
First Online: 9 August 2025
Declarations
:
: NMR is the co-founder, CEO and CSO, and a shareholder of Histofy Ltd. He is also the GSK Chair of Computational Pathology and is in receipt of research funding from GSK and AstraZeneca. SAK. is a shareholder of Histofy Ltd. All other authors have no competing interests to declare.
: Health and Care Research Wales ethics reference: 20/WS/0017.
